TransMedics (TMDX) Total Liabilities (2018 - 2026)

TransMedics' Total Liabilities history runs 9 years deep, the most recent figure standing at $940.8 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 64.7% year-over-year to $940.8 million in Q1 2026; TTM through Mar 2026 was $940.8 million, a 64.7% increase from a year earlier, with the FY2025 full-year figure at $595.3 million, up 3.44% from the prior year.
• Total Liabilities advanced to $940.8 million in Q1 2026 per TMDX's latest filing, from $595.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $940.8 million in Q1 2026 and bottomed at $64.1 million in Q1 2022.
• The 5-year median for Total Liabilities is $568.7 million (2024), against an average of $449.0 million.
• Across the five-year window, Total Liabilities surged 721.42% in 2023 and gained 0.66% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $89.8 million in 2022, then soared by 533.66% to $568.8 million in 2023, then grew by 1.17% to $575.5 million in 2024, then grew by 3.44% to $595.3 million in 2025, then jumped by 58.05% to $940.8 million in 2026.
• Per Business Quant, the three latest TMDX Total Liabilities figures stand at $940.8 million (Q1 2026), $595.3 million (Q4 2025), and $590.8 million (Q3 2025).